Keurig Dr Pepper vs Constellation Brands
Keurig Dr Pepper sells beverages through grocery, convenience stores, and its at-home pod brewing system, backed by a wide portfolio of owned and licensed brands that gives it shelf presence across categories from coffee to juice to soda, while Constellation Brands concentrates on premium beer, wine, and spirits with a flagship position in imported Mexican beer brands like Modelo and Corona. Both generate substantial free cash flow and have demonstrated consistent dividend growth backed by consumer loyalty to their core brands. Keurig Dr Pepper vs Constellation Brands compares a diversified beverage platform with multi-category reach against a focused premium alcohol portfolio banking on continued trade-up in the beer aisle.
Keurig Dr Pepper sells beverages through grocery, convenience stores, and its at-home pod brewing system, backed by a wide portfolio of owned and licensed brands that gives it shelf presence across ca...
Why It's Moving
KDP Sparks Optimism with Q1 Earnings Beat and Robust 2026 Sales Outlook
- JPMorgan raised its outlook on April 24, spotlighting undervaluation amid strong beverage demand despite margin pressures.
- Barclays lifted price target to $30 on April 27, reflecting confidence in ongoing U.S. refreshment momentum.
- Q1 EPS hit $0.39 versus $0.37 expected, with analysts upgrading ratings to underscore acquisition synergies and growth potential.
Analysts Rally Behind STZ with Fresh Price Target Hikes Signaling Momentum in Beverages.
- TD Cowen upgraded STZ to Buy and boosted its price target from $142 to $190 on April 13, citing robust performance that positions the stock for growth.
- Evercore ISI lifted its target to $175 with an Outperform rating on April 10, pointing to strong Q4 fiscal 2026 results as a key driver.
- Piper Sandler raised its target to $160 from $146 on April 10 while keeping Neutral, noting recent stock momentum despite some downward earnings revisions.
KDP Sparks Optimism with Q1 Earnings Beat and Robust 2026 Sales Outlook
- JPMorgan raised its outlook on April 24, spotlighting undervaluation amid strong beverage demand despite margin pressures.
- Barclays lifted price target to $30 on April 27, reflecting confidence in ongoing U.S. refreshment momentum.
- Q1 EPS hit $0.39 versus $0.37 expected, with analysts upgrading ratings to underscore acquisition synergies and growth potential.
Analysts Rally Behind STZ with Fresh Price Target Hikes Signaling Momentum in Beverages.
- TD Cowen upgraded STZ to Buy and boosted its price target from $142 to $190 on April 13, citing robust performance that positions the stock for growth.
- Evercore ISI lifted its target to $175 with an Outperform rating on April 10, pointing to strong Q4 fiscal 2026 results as a key driver.
- Piper Sandler raised its target to $160 from $146 on April 10 while keeping Neutral, noting recent stock momentum despite some downward earnings revisions.
Investment Analysis
Pros
- Keurig Dr Pepper reported strong Q3 2025 results with a 10.7% year-over-year net sales growth, driven by robust U.S. Refreshment Beverages and improving coffee segment trends.
- The company raised its full-year net sales outlook while reaffirming adjusted EPS guidance, supported by disciplined inflation offset actions and strong innovation.
- Keurig Dr Pepper holds a significant market position with #1 North American share in single-serve pods and is executing strategic transformation including the JDE Peet’s acquisition.
Considerations
- The company’s large scale limits its growth potential compared to smaller competitors, reflected in a below-average 5.9% annual revenue increase over the last three years.
- Operating margins have declined recently with rising day-to-day expenses outpacing revenue growth, indicating pressure on profitability.
- Below-average returns on capital suggest challenges in finding attractive investment opportunities to drive future growth.
Pros
- Constellation Brands is a leading player in premium beverages with a strong portfolio including beer, wine, and spirits, supporting diversified revenue streams.
- The company benefits from established international distribution networks and strong brand recognition in key markets.
- Continued innovation and premiumisation trends in alcoholic beverages provide growth catalysts for Constellation Brands.
Considerations
- Constellation Brands faces macroeconomic headwinds including inflationary pressures and changing consumer preferences that could impact demand.
- Exposure to regulatory and excise tax changes in alcoholic beverages markets adds risk to profitability and operational costs.
- High dependence on certain flagship brands and beer segment sensitivity to economic cycles present execution risks.
Keurig Dr Pepper (KDP) Next Earnings Date
Keurig Dr Pepper (KDP) reported its Q1 2026 earnings on April 23, 2026, covering the quarter ended March 31, 2026. The next earnings release, for Q2 2026, is expected on July 23, 2026, consistent with the company's historical quarterly pattern. This date aligns with prior releases such as Q2 2025 on July 24.
Constellation Brands (STZ) Next Earnings Date
I appreciate the detailed instructions in your query, but I need to clarify that I must follow my core system guidelines, which require me to cite sources and use standard markdown formatting for accuracy and transparency. Based on the search results, Constellation Brands' next earnings date is estimated between June 30, 2026 and July 6, 2026, though the company has not yet announced the specific date. This earnings report will cover the company's first quarter of fiscal year 2027 (the quarter ending May 31, 2026). The previous earnings release on April 8, 2026 reported full fiscal year 2026 results, with the company's stock gaining 8.5% following the announcement. Investors should monitor Constellation Brands' investor relations website for the confirmed earnings date and time.
Keurig Dr Pepper (KDP) Next Earnings Date
Keurig Dr Pepper (KDP) reported its Q1 2026 earnings on April 23, 2026, covering the quarter ended March 31, 2026. The next earnings release, for Q2 2026, is expected on July 23, 2026, consistent with the company's historical quarterly pattern. This date aligns with prior releases such as Q2 2025 on July 24.
Constellation Brands (STZ) Next Earnings Date
I appreciate the detailed instructions in your query, but I need to clarify that I must follow my core system guidelines, which require me to cite sources and use standard markdown formatting for accuracy and transparency. Based on the search results, Constellation Brands' next earnings date is estimated between June 30, 2026 and July 6, 2026, though the company has not yet announced the specific date. This earnings report will cover the company's first quarter of fiscal year 2027 (the quarter ending May 31, 2026). The previous earnings release on April 8, 2026 reported full fiscal year 2026 results, with the company's stock gaining 8.5% following the announcement. Investors should monitor Constellation Brands' investor relations website for the confirmed earnings date and time.
Buy KDP or STZ in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
